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A B S T R A C T
Red blood cells (RBCs) are stored up to 35–42 days at 2–6 °C in blood banks. During storage, the RBC membrane
is challenged by energy depletion, decreasing pH, altered cation homeostasis, and oxidative stress, leading to
several biochemical and morphological changes in RBCs and to shedding of extracellular vesicles (EVs) into the
storage medium. These changes are collectively known as RBC storage lesions. EVs accumulate in stored RBC
concentrates and are, thus, transfused into patients. The potency of EVs as bioactive effectors is largely ac-
knowledged, and EVs in RBC concentrates are suspected to mediate some adverse effects of transfusion. Several
studies have shown accumulation of lipid raft–associated proteins in RBC EVs during storage, whereas a com-
prehensive phospholipidomic study on RBCs and corresponding EVs during the clinical storage period is lacking.
Our mass spectrometric and chromatographic study shows that RBCs maintain their major phospholipid (PL)
content well during storage despite abundant vesiculation. The phospholipidomes were largely similar between
RBCs and EVs. No accumulation of raft lipids in EVs was seen, suggesting that the primary mechanism of RBC
vesiculation during storage might not be raft -based. Nonetheless, a slight tendency of EV PLs for shorter acyl
chains was observed.
1. Introduction
During storage, red blood cells (RBCs) undergo several biochemical
and morphological changes affecting their quality and function, leading
to altered membrane lipid bilayer asymmetry and to accumulation of
extracellular vesicles (EVs) and cell waste in the storage medium. These
changes are referred to as storage lesion [1–3]. The erythrocyte mem-
brane is a lipid bilayer consisting of asymmetrically distributed phos-
pholipids (PLs), sphingolipids, cholesterol, and proteins. RBCs lack a
nucleus and are incapable of de novo lipid and protein synthesis and
therefore depend on lipid exchange and acyl chain remodeling as the
mechanisms of PL repair and renewal [4,5]. The essential membrane PL
asymmetry is actively maintained by various lipid-translocating en-
zymes. Nevertheless, metabolic processes of RBC membranes are
heavily affected by cold blood bank storage.
RBCs have a special biconcave disc shape for maximization of the
surface area and flexibility. Membrane damage to RBCs disturbs rheo-
logical properties and increases fragility after transfusion possibly
leading to increased hemolysis and fast removal of the transfused
nonviable RBCs from the circulation [6]. Energy depletion and oxida-
tive damage to membrane proteins during RBC storage cause aberra-
tions in the membrane microstructure. The correct membrane bilayer
lipid asymmetry is lost, which has been postulated as an essential me-
chanism of RBC vesiculation [7]. EVs, like their parent cells, possess a
membrane bilayer. EVs may act as bioactive effectors: they transport
molecules between cells, carry membrane antigens, and take part in
signaling and affect several biological processes in recipient cells [8,9].
Accumulating EVs are suspected to have inflammatory, im-
munomodulatory, and procoagulant effects on blood recipients
[10–15], potentially weakening the overall benefits of transfusion.
Phosphatidylserine (PS) is normally found only on inner leaflets of
cell membranes and when exposed, functions as a signal for
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phagocytosis and activation of coagulation [16]. Thus, removal of the
externalized PS from RBCs via vesiculation may serve as a survival
mechanism for RBCs [7], and in theory, can lead to enrichment of
certain PS species in EV membranes. Besides, functionally active lipid
rafts, enriched in e.g. cholesterol and sphingolipids [17] are believed to
be involved in RBC vesiculation, meaning that there could be controlled
inclusion of specific lipids into EVs. Lipid raft–associated proteins have
been shown to accumulate in RBC EVs during storage [18–21], and
sphingomyelin (SM) has been generally reported to get enriched in EVs
of various origins compared to their parent cells [8,22].
The lipid composition of the erythrocyte membrane is thoroughly
characterized at the PL class level as the erythrocyte has been used as a
model cell in biomembrane lipidomic studies [23–25]. PL composition
at the molecular species level has been less studied [26–28], and a
storage time–dependent study on RBCs and corresponding EVs is
lacking. Accordingly, we aimed to study the time course of changes in
PL classes and species of packed RBCs and the corresponding EVs
during a clinically relevant storage period. We were interested in pos-
sible lipid alterations in RBC membranes as a mechanism underlying
RBC storage lesion. We hypothesized some differences exist in PL
composition between EVs and RBCs in the course of RBC product aging.
2. Materials and methods
2.1. Packed RBCs
Ethical considerations: Only RBC concentrates that were not needed
for clinical use were used in the study. The research use is in accordance
with the rules of the Finnish Supervisory Authority for Welfare and
Health (Valvira).
We analyzed altogether 10 standard leukoreduced RBC concentrates
of blood type B+, obtained from the Finnish Red Cross Blood Service
(FRCBS), stored in the saline-adenine-glucose-mannitol (SAGM) ad-
ditive solution with citrate-phosphate-dextrose (CPD) anticoagulant at
2–6 °C under standard blood bank conditions. The maximum storage
duration for RBC products in Finland is 35 days. First pilot storage
experiment consisted of four and the second six RBC concentrates.
Samples were taken at 2, 8, 15, 22, and 36 days of age of the blood
products (Fig. 1). At each time point, the RBC concentrates were
thoroughly mixed, and 3 mL of RBCs was aseptically drawn from the
bag for routine in vitro quality control testing, and 17 mL for other
analyses. For collection of RBC lipid samples, 0.5 mL of the original
RBC concentrate was resuspended in 2 mL of the SAGM solution and
centrifuged for 20 min at room temperature (RT) and 805×g without a
brake (Eppendorf centrifuge 5810R). Pelleted RBC samples were stored
at −80 °C under argon in glass vials until lipid extraction.
Quality control measurements for RBC concentrates are described in
Supplementary methods.
2.2. EV isolation and characterization
2.2.1. EV isolation
The EVs were collected and analyzed only from the second storage
experiment (n= 6). For EV collection and for removal of the cells,
15 mL of an RBC concentrate was diluted with 15 mL of phosphate-
buffered saline (PBS, Sigma-Aldrich, Darmstadt, Germany) and cen-
trifuged two times for 20 min at 805×g and RT without a brake. The
resulting supernatant was ultracentrifuged for 1 h at 100000×g
(+4 °C, fixed-angle MLA-50 rotor, Beckman Coulter, Indianapolis, IN,
USA) to obtain EVs. The EVs were washed once with PBS, ultra-
centrifuged for 1 h at 100000×g (+4 °C, swing out MLS-50 rotor,
Beckman Coulter) and resuspended in 1 mL of PBS and stored at
−80 °C in aliquots for further analysis. For electron microscopy (EM),
EVs were isolated from additional RBC concentrates (n = 4) early (2-d)
and late (36-d) time point of storage and prepared freshly without
freezing.
2.2.2. Nanoparticle tracking analysis
To study the concentration and size distributions of EVs in RBC
samples (n = 6), 0.5 mL of the original RBC concentrate was re-
suspended in 2 mL of the SAGM solution and centrifuged two times for
20 min at RT and 805×g without a brake (Eppendorf centrifuge
5810R). The resulting supernatant was analyzed for particle content by
nanoparticle-tracking analysis (NTA; instrument LM14C with violet
laser 405 nm, 70 mW, Malvern Instruments Ltd., Malvern, UK) and a
sCMOS camera (Hamamatsu Photonics K.K., Hamamatsu City, Japan).
The samples were injected manually, and data acquisition was con-
ducted at ambient temperature in triplicate using the NanoSight soft-
ware v. 2.3 (Malvern Instruments Ltd.). Settings for data acquisition
were as follows: basic, camera level 14, autosettings off, polydispersity
and reproducibility high, with particles per image 40–100 (acquisition
time 90 s). Data were analyzed in the NanoSight software v. 3.0
(Malvern Instruments Ltd.) with threshold 5 and gain 10.
2.2.3. Western blot
Pelleted EV samples (2 and 36 d) were further characterized by
western blotting for the origin of EVs. Equal amounts of protein (2.5 μg)
were loaded and run on a TGX Mini-Protean 10% gel (Bio-Rad
Laboratories, Hercules, CA, USA) and subsequently electrophoretically
transferred to nitrocellulose membranes (BioRad). Nonspecific binding
was blocked with either 5% milk-0.1% Tween 20-PBS or 3% BSA-0.05%
Tween 20-PBS (overnight, +4 °C). Rabbit anti-human CD235a (1:1000
dilution, clone EPR8200, Abcam, Cambridge, UK), mouse anti-human
Hb (1:5000, clone 7E1F, Abcam), mouse anti-human CD61 (1:1000,
Fig. 1. The experimental set up. First storage experi-
ment consisted of four and the second six red blood
cell (RBC) concentrates. Extracellular vesicles (EVs)
were collected and analyzed only from the second
storage experiment (n = 6). RBC concentrates
(n = 10) were stored under standard blood banking
conditions. Samples were taken at 2, 8, 15, 22, and
36 days of age of the blood products. Mass spectro-
metric phospholipid (PL) analysis of RBCs (n = 10),
quality control (QC) measurements (n = 10), and na-
noparticle-tracking analysis (NTA, n = 6) were con-
ducted at each time point. EV (n = 6) PL analysis was
performed on 2-d, 15-d, and 36-d samples, and wes-
tern blot on 2-d and 36-d samples. EV samples for
electron microscopy (EM) were collected at 2 and
36 days of storage (n = 4). High-performance thin-
layer chromatography (HPTLC) analysis of PL classes
from RBC (n = 9) and EV (n = 7) samples was per-
formed at late time point (33–36 d) of storage only.
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clone VI-PL2, BD), mouse anti-human apolipoprotein A1 (Apo-A1;
1:1000, Medix Biochemica, Espoo, Finland), and mouse anti-human β-
actin (1:1000, clone AC-74, Sigma) antibodies were incubated in either
5% milk-0.1% Tween 20-PBS or 3% BSA-0.05% Tween 20-PBS (1 h,
RT), followed by incubation with a horseradish peroxidase-conjugated
goat anti-rabbit and goat anti-mouse IgG (H + L) secondary antibodies
(1:3000 dilution, 1 h, RT, Bio-Rad Laboratories). The enhanced che-
miluminescence (ECL) reagent/kit (GE Healthcare, Amersham, Little
Chalfont, UK) was used for detection of results.
2.2.4. Scanning electron microscopy (SEM)
EVs were collected as described in subsection 2.2.1 from four RBC
concentrates after 2 and 36 d of storage and processed the same day. In
total, 50–75 μL of concentrated EVs was placed on concanavalin A
(Sigma-Aldrich)–coated glass cover slips and fixed with 5% glutar-
aldehyde (G7651 Sigma, EM quality) in 0.05 M HEPES buffer (pH 7.2)
for 30 min and washed repeatedly with 0.05 M HEPES buffer and stored
in a buffer solution until the next day. Samples were post-fixed with 1%
OsO4 and dehydrated in an increasing gradient of ethanol. Samples
were allowed to dry on hexamethyldisilazane and were imaged im-
mediately. Before microscopy, the samples were coated with platinum.
SEM analyses were conducted by means of a FEG-SEM Quanta 250
microscope (FEI Company, Hillsboro, OR, USA). Diameter of EVs was
measured manually in Fiji platform (ImageJ 1.51n, http://imagej.nih.
gov/ij) from 2-d (n = 156 EVs) and 36-d (n = 154 EVs) images (n = 3
individuals in both time points).
2.3. Sample preparation for mass spectrometry
Lipids were extracted from RBCs, first from four and subsequently
from six RBC concentrates (altogether n = 10) stored for 2, 8, 15, 22,
and 36 days. From the second storage experiment corresponding EVs
(n = 6) were collected (2, 15, and 36 days) by the Folch extraction of
total lipids [29]. Briefly, the RBC pellet, approximately 0.5 mL, was
mixed with 3 mL of MeOH. Next, 0.45 mL of H2O and 3 mL of MeOH
was added to the sample and mixed thoroughly. One mL of the sample
was mixed with 0.32 mL of H2O and 2.2 mL of MeOH, followed by lipid
extraction as described elsewhere [29]. The EV sample, 0.25 mL in PBS,
was diluted with water to a final volume of 0.45 mL before the lipid
extraction.
2.4. Electrospray ionization mass spectrometry of PL species
The analytical methods used for PL species profiling followed in
principle the guidelines published previously [30,31]. A 6490 Triple
Quad LC-MS/MS system (Agilent Technologies, Santa Clara, CA, USA)
was used, and the lipid extracts of the RBCs and EVs were infused into
the mass spectrometer (MS) in chloroform/methanol (1:2) with 1%
NH4OH; the lipid species were detected by means of the class-specific
MS/MS scans [32]. The sample solutions were introduced into the MS
ion source by a Harvard syringe pump at a steady rate of 10 μL/min,
and nitrogen served as the nebulizing and drying gas. The EV samples
contained lipophilic compounds suppressing lipid ionization during
direct infusion into the ion source of the MS apparatus. Running the EV
samples with LC pre-separation [a C18 column and common ammo-
niated acetonitrile-isopropanol solvent system, details in [33]] dimin-
ished the artefact effects and allowed for more sensitive detection by
means of the class-specific MS/MS scans. To verify the comparability of
different methods, RBC samples (n= 6) containing the same internal
standards were analyzed by both the direct infusion and the LC-MS/MS
method. The samples were spiked with the same appropriate cocktail of
internal standards enabling correction for the effects of carbon chain
lengths on the detector response. The potentials of the spray needle,
capillary, and electric guides, and the collision energies were optimized
separately for different lipid classes. Full-scan mass spectra ranging
from m/z 400 to 1000 were collected in both positive and negative
ionization modes. In addition to the MS+ and MS- scans, an MS/MS
precursor ion scan was used to detect the diacyl species of phosphati-
dylcholine (PC) and SM (precursors for the fragment ion m/z 184), and
MS/MS neutral loss (NL) scans were applied to detect the diacyl species
of phosphatidylethanolamine (PE) (NL141) and PS species (NL87). The
saved spectra were averaged using the Mass Hunter software (Agilent).
Further data analysis for RBCs was performed in the LIMSA software
[34].
2.5. High-performance thin-layer chromatography (HPTLC) of lipid classes
Relative composition of the major lipid classes in RBCs and EVs was
determined by HPTLC. Samples were collected from additional RBC
concentrates at 33–36 days of age (n = 9). EVs were isolated from
100 mL and RBCs from 0.2 ml of a blood product, and lipids were ex-
tracted as described above. Silica plates (HPTLC Silica Gel 60 F254,
20 × 10 cm, Merck, Darmstadt, Germany) were prewashed with a
blank development solution (chloroform/methanol 1:1) and were dried
for at least 48 h in a desiccator. Sample aliquots (20 μL, in chloroform/
methanol 1:2) and standards for each lipid class were applied onto silica
plates by a CAMAG Automatic TLC Sampler 4 (CAMAG, Muttenz,
Switzerland). The PLs were separated on the plates in a horizontal
developing chamber by means of chloroform/methanol/acetic acid/
water (60:50:1:3.5) as the eluent, and the free cholesterol was sepa-
rated on another plate by hexane/diethylether/acetic acid/water
(26:6:0.4:0.1). The plates were stained by dipping them into a 3%
CuSO4·5H2O + 8% H3PO4 aqueous solution and by heating them on a
hot plate until visible sample bands appeared. The lipids were quanti-
fied by scanning the plates on a ChemiDoc Touch Imaging System (Bio-
Rad) and comparing the signal areas to those of authentic lipid stan-
dards (Avanti Polar lipids, Alabaster, Alabama, USA) for each lipid
class.
2.6. Statistical analyses
To study the statistical significance of PL class changes and mole-
cular species changes during storage, the related-samples Friedman test
for one-way repeated-measures analysis of variance was used, and to
compare independent samples, the Mann-Whitney U test was used. For
NTA and SEM measurements the Mann-Whitney U test was used.
Differences with a P value< 0.05 were considered statistically sig-
nificant. Analysis was performed in SPSS v.23.0 (IBM Corp., Armonk,
NY, USA).
3. Results
3.1. Quality control of packed RBCs
Comparable changes were observed in quality control measure-
ments during storage relative to those described in the literature (de-
scribed in more detail in Supplementary results, Supplementary Fig. 1).
3.2. Characterization of EVs
The numbers of particles varied substantially among individual
blood concentrates. In all six samples, we found that the particle con-
centration increased during storage (Fig. 2a). Median particle con-
centration was 5.39 × 108/mL (day 2), 17.48 × 108/mL (day 15), and
86.29 × 108/mL (day 36). The greatest increase in the particle con-
centration was between days 22 and 36 of storage. In the size dis-
tribution of particles, we observed a statistically significant shift toward
a smaller vesicle size during storage (Fig. 2b). Most of the particles
(90%) were 100–300 nm in size. In fresh (compared to 36-d) samples,
there were significantly more particles sized over 300 nm, but also
slightly more small particles sized< 100 nm.
To evaluate the origin of EVs in the RBC concentrates, we studied
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the expression of the RBC surface marker CD235a, Hb, the platelet
surface marker CD61, and the high-density lipoprotein (HDL) marker
apolipoprotein A1 (ApoA1) in the EVs by western blotting. The RBC
marker CD235a and Hb were present in all the samples (Fig. 2c). Pla-
telet marker CD61 was not visible in the RBC EVs, while in the platelet
EV sample, it was clearly present (Supplementary Fig. 2). In addition, a
minor ApoA1 band was detected, especially in some 2-d samples
(Fig. 2c). Nevertheless, the amounts of the other markers did not seem
increase during storage; therefore, the EVs in the older RBC con-
centrates were mostly of RBC origin. Some minor contamination with
EVs from other cells can be present due to a small residue of plasma in
the production process (maximum 20 mL per RBC concentrate).
SEM was performed on EVs from fresh (2 d) and aged (36 d) RBC
concentrates (n= 4). The amount of EVs was negligible in samples
from early storage, but different sizes and shapes were still evident
(Fig. 2d inset). The samples from late storage contained a lot of EVs of a
wide variety of shapes and sizes (Fig. 2d). Mean diameter and also the
diversity of 2-d EVs (352.6 nm,± 215.6) was greater than that of 36-d
EVs (266.0 nm,± 93.2) (Supplementary Fig. 3).
3.3. PL composition of RBCs and EVs
The PL profiles of RBCs remained rather constant during storage
(2–36 d) and no statistically significant differences in the lipid profiles
were seen at the class level as analyzed by ESI-MS/MS (Supplementary
Fig. 4, n = 10). These results are comparable to the reported results for
RBCs from fresh blood [26]. The EV samples contained substances that
interfered with the MS detection of phosphatidylethanolamine plas-
malogen species (PEp), for which no sensitive specific MS/MS detection
mode exists. Therefore, the relative composition of the four major PL
classes (PC, PE, PS, and SM) of EVs and RBCs was then compared by
HPTLC at a late time point of storage (33–36 d). These samples con-
tained only low concentrations of lipoprotein and platelet markers and
thus were the purest RBC-derived EVs. There were no significant dif-
ferences between the PL class profiles of EVs and RBCs, and no en-
richment of PS or SM in EVs was found (Fig. 3). In addition, choles-
terol/PL ratio was not statistically different between RBCs and EVs
(0.64 ± 0.02 compared to 0.52 ± 0.12, respectively, n = 4). In
general, EV lipid composition had more variation between individual
donors.
During storage, the molecular species profiles of RBCs showed few
statistically significant changes in the main PL classes (Fig. 4), but the
absolute shifts were no more than 2 mol% in any one of the PL species.
The changes in the individual PL species owing to storage were more
numerous in EVs than in RBCs (Fig. 4). In general, the molecular species
of PC and SM, enriched on the outer leaflet of the membrane were al-
tered more than the molecular species of PE and PS, found pre-
dominantly on the inner leaflet of the membrane [25]. A subtle ten-
dency for PLs with relatively short acyl chains at the expense of PLs
with longer unsaturated chains was observed in EVs during the storage
in comparison with RBCs. The differences, though statistically sig-
nificant in some details, remained minor in general. There was high
Fig. 2. EV characterization. EV concentration and size distribution were evaluated in an RBC-free supernatant by nanoparticle-tracking analysis (NTA) (n = 6). EV concentration
increased considerably during storage (A) and a statistically significant shift toward a smaller EV size was observed (size in nm) (B). Western blot analysis of day 2 and day 36 EV samples
shows that CD235a and hemoglobin (Hb) were present in EVs, while CD61 was absent, and ApoA1 amounts were negligible. β-actin was used as a loading control. (C). Scanning electron
microscopy reveals a wide variety of shapes and sizes in EVs from a 36-day-old RBC concentrate, scale bar 1 μm. Inset is from 2-day-old RBC concentrate, scale bar 0.5 μm. (D). NTA
results are shown as mean ± SD, and statistical significance was analyzed by the Mann-Whitney U test (*p < 0.05; **p < 0.01; ***p < 0.001).
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individual variation among EV samples, especially at the early time
points, possibly reflecting the presence of varying amounts of lipopro-
tein and platelet material (Fig. 2c).
Both RBCs and EVs had largely similar PL molecular species com-
position. We focused on the comparison of 36-d EVs and RBCs owing to
the best purity of the EV samples at the end of the storage, when they
were mainly composed of RBC-derived EVs (Fig. 5). The largest dif-
ferences between EVs and RBCs and the largest individual variation
were seen in PE diacyl species. The most remarkable difference on day
36 was in PE 38:4, whose amount was found to be substantially less in
EVs than in RBCs. Additionally, less PE 38:7, PE 36:5, and PE 36:2 and
respectively more PE 36:1 and PE 36:4 was detected in EVs compared to
RBCs. The PS species profiles were the most stable during storage, and
only negligible differences between EVs and RBCs were observed. In SM
species, there was significantly more SM 16:1 and SM 24:0 in EVs and
more SM 22:1 and SM 24:2 in RBCs. A slight general pattern of favoring
shorter chains in EV PLs and longer chains with a higher degree of
unsaturation in RBC PLs were seen in each PL class.
4. Discussion
The PL compositions of our blood bank–stored RBCs well matched
the known RBC lipidomes described at the class level [24,25] and at the
species level for RBCs obtained from fresh blood [26]. Contrary to our
expectations, we did not detect any major differences in PL class and
species compositions between stored RBCs and the corresponding EVs.
Thus, no systematic PL content alterations could be detected in RBCs as
a sign of storage lesion.
RBCs exchange PLs, outer-leaflet lipids PC and SM in particular,
with plasma lipoproteins, and a diet change or aberrations in plasma
lipoproteins induce changes in RBC membranes. The lipid turnover rate
in RBCs is slow, and it takes up to one month to see diet-induced
changes in vivo [4,5]. The acyl chains of PS and PE, residing in the
inner membrane leaflet, can be slowly replaced via ATP-dependent
incorporation mechanisms [35]. In cold storage, ATP depletion is
known to take place [1], and lipid metabolism is probably slowed
down. During storage, we observed substantially more alterations in the
outer-leaflet PL profiles, while composition of the inner-leaflet PL
species remained more stable both in EVs and RBCs. This finding is in
agreement with the fact that in stored RBC concentrates, there is no de
novo source of PLs, but the material for lipid exchange and fatty-acid
acylation is limited to existing membrane and lipoprotein particles
present in the blood product during RBC collection.
During early RBC storage, the amount of EVs in general is miniscule,
Fig. 3. The relative amounts of four major phospholipid (PL) classes of the RBCs (n = 9)
and the EVs (n = 7) collected from RBC concentrates at 33–36 d of storage. Lipids were
analyzed by high-performance thin-layer chromatography. The values are weight per-
centages for each class when the sum of the four main PL classes was set to 100%. PL,
phospholipid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; SM, sphingo-
myelin; PS, phosphatidylserine.
Fig. 4. Molecular species of four major phospholipid (PL) classes in RBCs (n = 10) and EVs (n = 6) at 2-d, 15-d, and 36-d time points of storage. More numerous statistically significant
changes as a function of storage duration are observed in outer-leaflet sphingomyelin (SM) (A) and phosphatidylcholine (PC) diacyl species (B) than in phosphatidylserine (PS) (C) and
phosphatidylethanolamine (PE) diacyl species. Results are shown as mean molar percentages (mol % ± SD). Statistical significance was analyzed by Friedman's test for one-way
repeated-measures analysis of variance (*p < 0.05; **p < 0.01; ***p < 0.001, red color indicates EVs, and black color RBCs).
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and possible contaminating lipoproteins and EVs from cell sources
other than RBCs make a relatively larger contribution to the lipid
content. Some lipoprotein particles from residual plasma are likely to
remain in the EV aliquot during the ultracentrifugation process [36]. As
proof, we did find a faint band of the HDL marker Apo-A1 in our EV
samples, manifesting more at an early time point. It has been suggested
that stored RBC concentrates may contain a substantial proportion of
platelet-derived EVs [14], especially in the beginning of storage, be-
cause platelets are known to vesiculate actively. Nevertheless, we be-
lieve that this is unlikely, especially later in storage, because the pla-
telet contamination compared to RBC mass is minimal. In addition, we
did not detect platelet marker CD61 in our EV samples. The similarity of
PLs between RBCs and the associated EVs adds to the proof that the
majority of EVs found in RBC products are RBC-derived. In the later
storage, the relative amount of RBC-derived EVs became much greater
and the significance of possible contaminating lipids decreased; there-
fore, we consider the lipid data from 36-d EVs more reliable.
We did not observe significant differences between the PL class
compositions of EVs and RBCs. Accumulation of PS in EVs was not
observed, indicating no augmented removal of PS from RBCs via vesi-
culation. In fact, the changes in PS species with respect to time (or when
comparing RBC and EV PS profiles) were the smallest. Despite the re-
ported accumulation of lipid raft– associated proteins in stored RBC EVs
[18–21], our data indicate no enrichment of raft-associated lipid SM in
EVs, as has been suggested for exosomes, which are EVs of endosomal
origin [22]. Furthermore, we did not observe enrichment of cholesterol,
another raft– associated lipid, in EVs compared to RBCs. Thus, based on
our results, raft– based process does not seem to be the major me-
chanism in storage– associated RBC vesiculation. Unfortunately, we
were not able to study molecular distribution of PLs or changes in lipid
asymmetry, as that has been proposed as an essential mechanism of
RBC vesiculation during storage [7]. Nevertheless, that may not ne-
cessarily cause major, systematic differences in PL composition between
EVs and RBCs, at least according to our data. This is different from the
selective sorting of proteins seen in RBC EVs during aging and, e.g.,
band 3- or protein oxidization– related mechanisms for vesicle gen-
eration from RBCs have been suggested [37].
PL profiles of RBC molecular species and of the corresponding EV
molecular species have not been extensively compared before. Stored
human RBCs and their EVs have been previously compared by only one
group, who reported differences in PS molecular species profiles of
RBCs and EVs in an outdated product [27]. They stated that 38:1 is the
main PS species in aged packed RBCs. The fact that RBCs analyzed in
their study were very old, could explain their contradictory finding to
ours. Large amounts of carbon chains this long with only one double
bond may lower membrane fluidity and would not be expected to be
favorable in cell membranes. In addition, 20- or 22‑carbon saturated or
monounsaturated fatty acids, which most likely comprise one of the two
chains in PS 38:1, have not been found in significant amounts in RBCs
[3,23,35,38,39]. Moreover, we did not detect a significant amount of
this PS species in RBCs at any time point, but instead a large relative
amount of PS 38:4, in line with another study [26]. The lipid profile of
EVs collected from outdated RBC product reported by Bicalho et al. is
substantially similar to the lipid profiles of both our RBCs and EVs [27].
In EVs, the PL acyl chains were slightly shorter than those in RBCs.
This result could be explained by the differences between the surface
areas of the two membrane leaflets, where the difference is much larger
in the small EVs compared to the parent cells. When the relative area of
the inner leaflet gets smaller, it should be seen as a relative loss of cone-
shaped PLs such as PE species with long and highly unsaturated acyl
chains, e.g., PE 38:4. This membrane curvature effect could theoreti-
cally lead to some physicochemically-driven selection of lipids to ac-
complish energetically favorable packing of the membrane [40–42]. In
addition, the shorter chains, even one, influence the efflux properties of
the PL molecules. For example, PE 36:4, which was favored in EVs at
the expense of PE 38:4, has a higher chemical activity than 38:4 does,
and is preferred as a substrate by phospholipases [43]. This phenom-
enon is worth noticing when addressing the biological effects of
Fig. 5. A comparison of molecular species of four major phospholipid (PL) classes in RBCs (n = 10) and EVs (n = 6) at 36 d of storage. Results are shown as mean mol% ± SD. Statistical
significance was assessed by the Mann-Whitney U test (*p < 0.05; **p < 0.01; ***p < 0.001).
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transfused EVs.
We saw EVs of varying morphology. It is possible that EVs of dif-
ferent size and morphology have different functional qualities. PL
shape, size, and charge affect their tendency to form bilayer membranes
of different curvature, and also the associated membrane proteins in-
fluence on the tendency to form certain shapes [40]. Therefore, EVs of
different morphology may consist of different types of PLs and proteins.
We were not able to separate and isolate EVs with different morpho-
logical features to perform further analysis. Some of the EVs seemed to
be about to split in half or budding, thus creating smaller daughter EVs,
but this phenomenon could not be solidly confirmed by SEM imaging.
The EV size distribution shifted toward smaller EV sizes during storage,
in line with this theory, supported both by NTA and SEM results.
Contrary to our results, it has been proposed that RBC EVs increase in
size during storage and fusion might be one possible mechanism
[20,44]. EV shape and formation may be a dynamic process, and EV
shapes may constantly change in the medium. Additionally, the ultra-
centrifugation process may cause alterations in EV morphology [45].
Our study has some limitations. Mass spectrometric analysis of EVs
was challenging due to a very low amount of the sample. In particular,
the negative ionization mode of the MS, less sensitive to start with than
the positive ionization mode, was hampered by the presence of con-
taminants. On day two, the amount of EVs, and thus the material being
analyzed, was much smaller as compared to day 36, thereby leading to
different intensity of the MS signals. This effect caused higher deviation
in the day 2 data for methodological reasons. Owing to the small
amount of the EV material, we were able to include only three time
points and analyze only the four largest PL classes and had to leave out
more minor groups such as bioactive lyso-PC and ceramides, although
those could have functional importance. PEp species could not be re-
liably analyzed in EVs because of the lack of a specific detection mode
sensitive enough. In addition, we were only able to study a pool of all
EVs with different sizes and morphologies, thus, the possible compo-
sitional changes in PLs in different EV subtypes during storage of RBCs
concentrate requires further studies.
The strengths of our study: We analyzed the four major PLs of both
RBCs and EVs derived from the same RBC concentrates from early,
middle and late time points of storage within the Finnish clinical usage
period to enable a rational comparison. Species level PL analysis of
packed RBCs has been done only by one other research group with
partly conflicting results [27,28]. In our study, several appropriate MS
scans were run for each type of lipid to obtain reliable results not biased
by adducts and other contaminants. Because of challenges in the MS
analysis of PE plasmalogen species in EVs, the PL class level comparison
between RBCs and EVs was carried out by HPTLC.
5. Conclusions
Our results indicate abundant RBC-derived vesiculation, and al-
though greatly increasing during storage, vesiculation does not seem to
disturb RBC membrane PL composition of the four major PL classes. The
lipid content of RBCs and the corresponding EVs bear a high resem-
blance. During storage, in EVs, a subtle tendency for accumulating PL
species with shorter chains was observed. There was no accumulation
of raft lipids in EVs, indicating that the main mechanism of RBC vesi-
culation during storage may not be raft-based. The PL content of RBCs
seems to stay relatively unchanged during clinical storage time, sug-
gesting that PL compositional alterations may not be among the main
mechanisms behind RBC storage lesion.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbalip.2017.09.012.
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